|
|
||||||||
Animal: DNA Viruses |
Laboratory of Antiviral Chemotherapy1 and Laboratory of Molecular Immunology2, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
Author for correspondence: Graciela Andrei. Fax +32 16 337340. e-mail graciela.andrei{at}rega.kuleuven.ac.be
Drug-resistant strains of herpes simplex virus type 1 (HSV-1) were selected under the pressure of (S)-3-hydroxy-2-phosphonylmethoxypropyl (HPMP) derivatives of cytosine (HPMPC, cidofovir) and adenine (HPMPA) and 2-phosphonylmethoxyethyl (PME) derivatives of adenine (PMEA, adefovir) and 2,6-diaminopurine (PMEDAP). HPMPC-resistant (HPMPCr) and HPMPAr strains were cross-resistant to one another, but they remained sensitive to foscarnet (PFA), acyclovir (ACV) and the PME derivatives, while the PMEAr and PMEDAPr strains showed cross-resistance to PFA and ACV. The PMEAr, PMEDAPr and PFAr mutants all revealed a single nucleotide change resulting in a Ser-724 to Asn mutation within the conserved region II of the DNA polymerase. Two HPMPAr clones and one HPMPCr clone possessed single amino acid changes in the DNA polymerase (HPMPAr clone D1, Leu-1007 to Met; HPMPAr clone B5, Ile-1028 to Thr; HPMPCr clone C3, Val-573 to Met). The HPMPCr clone A4 contained two mutations, Ala-136 to Thr and Arg-700 to Met. The mutation at position 136, located outside the catalytic domain of the enzyme, was not detected in other HPMPCr clones, suggesting that this mutation may not be responsible for the resistant phenotype. Residue 573 is located within the 3'
5' exonuclease editing domain close to the catalytically important residues Tyr-577 and Asp-581. Similarly, residue 700 is located in the palm subdomain of the catalytic domain, adjacent to the Asp residues 717, 886 and 888 that are vital for polymerase activity. The HPMPAr mutations at residues 1007 and 1028, beyond the last conserved region, still fall within the thumb subdomain of the catalytic domain. The different drug-resistant mutants varied in neurovirulent behaviour, the HPMPCr strains showing reduced neurovirulence compared with the wild-type.
This article has been cited by other articles:
![]() |
G. Andrei, D. B. Gammon, P. Fiten, E. De Clercq, G. Opdenakker, R. Snoeck, and D. H. Evans Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulence in Mice J. Virol., October 1, 2006; 80(19): 9391 - 9401. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Andrei, J. van den Oord, P. Fiten, G. Opdenakker, C. De Wolf-Peeters, E. De Clercq, and R. Snoeck Organotypic Epithelial Raft Cultures as a Model for Evaluating Compounds against Alphaherpesviruses Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4671 - 4680. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Andrei, J. Balzarini, P. Fiten, E. De Clercq, G. Opdenakker, and R. Snoeck Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin J. Virol., May 1, 2005; 79(9): 5863 - 5869. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. De Clercq Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections Clin. Microbiol. Rev., October 1, 2003; 16(4): 569 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bestman-Smith and G. Boivin Drug Resistance Patterns of Recombinant Herpes Simplex Virus DNA Polymerase Mutants Generated with a Set of Overlapping Cosmids and Plasmids J. Virol., July 15, 2003; 77(14): 7820 - 7829. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamiyama, M. Kurokawa, and K. Shiraki Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir J. Gen. Virol., November 1, 2001; 82(11): 2761 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manichanh, C. Olivier-Aubron, J.-P. Lagarde, J.-T. Aubin, P. Bossi, A. Gautheret-Dejean, J.-M. Huraux, and H. Agut Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo J. Gen. Virol., November 1, 2001; 82(11): 2767 - 2776. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Romanowski, Y. J. Gordon, T. Araullo-Cruz, K. A. Yates, and P. R. Kinchington The Antiviral Resistance and Replication of Cidofovir-Resistant Adenovirus Variants in the New Zealand White Rabbit Ocular Model Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1812 - 1815. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |